Cutaneous Leishmaniases Clinical Trial
Official title:
Spatial Analysis of Host-parasite Interactions in the Skin Across the Clinical Spectrum of Cutaneous Leishmaniasis in Ethiopia
Cutaneous leishmaniasis manifestations range from self-healing localized skin ulcers/nodules to diffusely spread chronic lesions. Knowledge on the host-parasite interactions underpinning the different clinical presentations is scarce, in particular for L. aethiopica infections where disease can be extremely severe. Our aim is to define differences in skin immune responses and parasite virulence in CL patients at single cell/parasite level and how it underpins the different clinical presentations (localised, mucocutaneous and diffuse), by producing the first spatially-resolved 'ecological' map of the lesions.
Specific objectives: 1. To profile the full heterogeneity in skin and lesion immunity (single cell RNAseq), and the cellular microenvironment surrounding infected and non-infected macrophages (digital spatial profiling). 2. To study the genomic diversity of L. aethiopica and identify features associated with the different clinical presentations (whole genome sequencing). 3. To understand how parasites respond to the microenvironmental conditions and define parasite survival niches (digital spatial profiling). 4. Study metabolic determinants of skin immunity (e.g. lipid metabolism, bioenergetics, short-chain fatty acids) in the context of key structural features of the skin landscape known to influence local metabolism and immune response (e.g. adipose tissue, follicles, microvasculature) (SpatialOMx). 5. To investigate the association between patient outcomes and the above host/parasite factors at baseline. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Suspended |
NCT03292835 -
Complex Cutaneous Leishmaniasis Healing Study in Algeria
|
||
| Terminated |
NCT03208543 -
Effectiveness, Safety and Feasibility of HECT-CL, in Quetta, Pakistan
|
Phase 3 | |
| Completed |
NCT04512742 -
A Clinical Study to Develop a Controlled Human Infection Model Using Leishmania Major-infected Sand Flies
|
N/A | |
| Completed |
NCT04004754 -
Outcomes of Complicated CL in Ethiopia Treated With Miltefosine
|
||
| Active, not recruiting |
NCT04515186 -
Combination, Miltefosine Monotherapy for Cutaneous Leishmaniasis in New World
|
Phase 3 | |
| Completed |
NCT02919605 -
Efficacy and Safety of Pentamidine (7mg/kg) for Patients With Cutaneous Leishmaniasis Caused by L. Guyanensis
|
Phase 2 | |
| Completed |
NCT03837431 -
Cutaneous Leishmaniasis Diagnostic Study
|
||
| Not yet recruiting |
NCT05493059 -
Study of Cases of Cutaneous Leishmaniasis Treated With Miltefosine in French Guiana, Retrospective Study
|
||
| Terminated |
NCT04001335 -
Diagnosis of Cutaneous Leishmaniasis Using the CL-detect Rapid Test in Travelers and Migrants in Belgium
|
||
| Completed |
NCT03929016 -
Single Oral Dose Escalation Study of DNDI-0690 in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT03435419 -
Evaluation of Point-of-care Tests for the Diagnosis of Cutaneous Leishmaniasis in Afghanistan
|
N/A |